Othmar Engelhardt, speaking at World Influenza Congress Europe 2011

Othmar Engelhardt,
Principal Scientist, Division of Virology
National Institute for Biologicals Standards and Control

Dr Othmar G Engelhardt is a Principal Scientist in the Division of Virology of the National Institute for Biological Standards and Control, a centre of the Health Protection Agency, UK. He received a doctorate degree from the University of Natural Resources and Applied Life Sciences, Vienna, Austria. Working at the Mount Sinai School of Medicine, New York, USA, the University of Freiburg, Germany, and the University of Oxford, UK, he has been involved in research into various aspects of influenza virus and other negative strand RNA viruses.
At NIBSC, he is involved in various aspects of NIBSC’s influenza work. His research involves the use of reverse genetics technology in deriving candidate influenza vaccine viruses. He was part of the team at NIBSC that produced candidate vaccine viruses in response to the emergence of the new pandemic influenza A(H1N1) virus.
He is responsible for the generation of candidate vaccine viruses for seasonal influenza by conventional reassortment techniques. His team produces reference reagents that are needed for the potency determination of inactivated influenza vaccines, and performs official batch release of influenza vaccines. He is involved in various WHO projects; this includes seasonal and pandemic influenza strain selection where NIBSC plays an important role as one of the four Essential Regulatory Laboratories (ERLs). He has served as temporary adviser to WHO on various influenza-related topics, and as technical expert at the EMA and the UK Department of Health.

Appearing:

Congress Day 1 – Tuesday 6th December 2011

9.40am

Government as an ally: commitment to bring flu vaccines to market sooner

Integrated, systematic approach to develop flu vaccines
Licensure of new vaccines for pandemic flu and impact on seasonal vaccines
Vision of pandemic flu vaccines
How can we stop playing catch up with seasonal flu?

Othmar Engelhardt,

Principal Scientist, Division of Virology,
National Institute for Biologicals Standards and Control

10.10am

Panel discussion: Review of the 2011 World Health Organisation recommendations for influenza vaccination composition

What has been garnered from the 2011 southern and northern hemisphere flu seasons?
What has been the basis of this season’s vaccine recommendation?
What are the consequences of a repeating seasonal influenza vaccine?

Othmar Engelhardt,

Principal Scientist, Division of Virology,
National Institute for Biologicals Standards and Control

John McCauley,

Division of Virology, WHO Collaborating Centre for Reference and Research on Influenza,
National Institute for Medical Research

Sponsor World Influenza Congress Europe 2011 ›

Silver Sponsor